114 related articles for article (PubMed ID: 10343153)
1. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture.
Satoh J; Kurohara K; Yukitake M; Kuroda Y
Eur Neurol; 1999; 41(4):216-25. PubMed ID: 10343153
[TBL] [Abstract][Full Text] [Related]
2. Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease.
Schmitz M; Schlomm M; Hasan B; Beekes M; Mitrova E; Korth C; Breil A; Carimalo J; Gawinecka J; Varges D; Zerr I
Eur J Neurosci; 2010 Jun; 31(11):2024-31. PubMed ID: 20529115
[TBL] [Abstract][Full Text] [Related]
3. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
[TBL] [Abstract][Full Text] [Related]
4. [Genetic background of human prion diseases].
Kovács GG
Ideggyogy Sz; 2007 Nov; 60(11-12):438-46. PubMed ID: 18198790
[TBL] [Abstract][Full Text] [Related]
5. The diagnosis of human prion diseases.
Kordek R
Folia Neuropathol; 2000; 38(4):151-60. PubMed ID: 11693717
[TBL] [Abstract][Full Text] [Related]
6. De novo P102L mutation in a patient with Gerstmann-Sträussler-Scheinker disease.
Kojović M; Glavač D; Ožek B; Zupan A; Popović M
Eur J Neurol; 2011 Dec; 18(12):e152-3. PubMed ID: 22097954
[No Abstract] [Full Text] [Related]
7. Differential expression of metallothioneins in human prion diseases.
Kawashima T; Doh-ura K; Torisu M; Uchida Y; Furuta A; Iwaki T
Dement Geriatr Cogn Disord; 2000; 11(5):251-62. PubMed ID: 10940676
[TBL] [Abstract][Full Text] [Related]
8. Neuropathological features of a case with schizophrenia and prion protein gene P102L mutation before onset of Gerstmann-Sträussler-Scheinker disease.
Sasaki K; Doh-ura K; Furuta A; Nakashima S; Morisada Y; Tateishi J; Iwaki T
Acta Neuropathol; 2003 Jul; 106(1):92-6. PubMed ID: 12682740
[TBL] [Abstract][Full Text] [Related]
9. Divergent clinical and neuropathological phenotype in a Gerstmann-Sträussler-Scheinker P102L family.
Popova SN; Tarvainen I; Capellari S; Parchi P; Hannikainen P; Pirinen E; Haapasalo H; Alafuzoff I
Acta Neurol Scand; 2012 Nov; 126(5):315-23. PubMed ID: 22211828
[TBL] [Abstract][Full Text] [Related]
10. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
11. [Mutation of codon 117 of the prion gene in Gerstmann-Sträussler-Scheinker disease].
Tranchant C; Doh-Ura K; Steinmetz G; Chevalier Y; Kitamoto T; Tateishi J; Warter JM
Rev Neurol (Paris); 1991; 147(4):274-8. PubMed ID: 2063076
[TBL] [Abstract][Full Text] [Related]
12. [Gerstmann-Sträussler-Scheinker syndrome with a Pro102Leu mutation in the prion protein gene and atypical MRI findings, hyperthermia, tachycardia, and hyperhidrosis].
Imaiso Y; Mitsuo K
Rinsho Shinkeigaku; 1998; 38(10-11):920-5. PubMed ID: 10203975
[TBL] [Abstract][Full Text] [Related]
13. [Gerstmann-Straüssler-Scheinker syndrome].
Tranchant C; Warter JM
Rev Neurol (Paris); 1998 Feb; 154(2):152-7. PubMed ID: 9773036
[TBL] [Abstract][Full Text] [Related]
14. A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient.
Jansen C; Parchi P; Capellari S; Strammiello R; Dopper EG; van Swieten JC; Kamphorst W; Rozemuller AJ
J Neuropathol Exp Neurol; 2011 Aug; 70(8):698-702. PubMed ID: 21760536
[TBL] [Abstract][Full Text] [Related]
15. Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker.
Kretzschmar HA; Honold G; Seitelberger F; Feucht M; Wessely P; Mehraein P; Budka H
Lancet; 1991 May; 337(8750):1160. PubMed ID: 1674033
[No Abstract] [Full Text] [Related]
16. Gerstmann-Sträussler-Scheinker disease. I. Human diseases.
Liberski PP; Budka H
Folia Neuropathol; 2004; 42 Suppl B():120-40. PubMed ID: 16903147
[TBL] [Abstract][Full Text] [Related]
17. Human brain disease recreated in mice.
Marx J
Science; 1990 Dec; 250(4987):1509-10. PubMed ID: 2274781
[No Abstract] [Full Text] [Related]
18. [A trend of molecular genetics on prion diseases and prion protein].
Muramatsu Y; Shinagawa M
Nihon Rinsho; 1993 Sep; 51(9):2494-502. PubMed ID: 8411733
[TBL] [Abstract][Full Text] [Related]
19. Reversible symptoms and clearance of mutant prion protein in an inducible model of a genetic prion disease in Drosophila melanogaster.
Murali A; Maue RA; Dolph PJ
Neurobiol Dis; 2014 Jul; 67():71-8. PubMed ID: 24686303
[TBL] [Abstract][Full Text] [Related]
20. The prion diseases: Creutzfeldt-Jakob, Gerstmann-Sträussler-Scheinker, and related disorders.
Mastrianni JA
J Geriatr Psychiatry Neurol; 1998; 11(2):78-97. PubMed ID: 9877529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
